Login Register Cart 0
Generic placeholder image

Letters in Drug Design & Discovery

Editor-in-Chief

ISSN (Print): 1570-1808
ISSN (Online): 1875-628X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Opportunities and Challenges in the Anticandidal Drug Discovery and Development

Author(s): Mohammad Abid

Volume 16, Issue 5, 2019

Page: [477 - 477] Pages: 1

DOI: 10.2174/157018081605190415121529

Next »
[1]
Dos Santos, A.T.L.; Machado, A.J.T.; De Freitas, M.A.; De Menezes, I.R.A.; Coutinho, H.D.M.; Da Cunha, F.A.B.; De Lima, E. Souza, D.D.S.; Boligon, A.A.; De Oliveira, A.S.; De Alencar Silva, A.; Morais-Braga, M.F.B. Phenolic composition and antifungal effect of Costus cf. arabicus L against yeast of the candida genus. Lett. Drug Des. Discov., 2019, 16(5), 502-511.
[2]
Qais, F.A.; Khan, M.S.A.; Ahmad, I.; Althubiani, A.S. Potential of nanoparticles in combating Candida infections. Lett. Drug Des. Discov., 2019, 16(5), 478-491.
[3]
Gurubasavaraj, P.M.; Charantimath, J.S. Recent advances in azole based scaffolds as anticandidal agents. Lett. Drug Des. Descov., 2019, 16(5), 492-501.
[4]
Rani, N.; Singh, R. Design, synthesis, antimicrobial evaluation and molecular modeling study of new 2-mercaptoimidazoles (Series-III). Lett. Drug Des. Discov., 2019, 16(5), 512-521.

Rights & Permissions Print Cite
Article Metrics
20
2
© 2024 Bentham Science Publishers | Privacy Policy